Provided by Tiger Fintech (Singapore) Pte. Ltd.

Neurocrine Biosciences

119.12
-1.4400-1.19%
Post-market: 119.120.00000.00%16:55 EDT
Volume:875.94K
Turnover:104.45M
Market Cap:11.79B
PE:40.28
High:120.10
Open:119.67
Low:118.39
Close:120.56
Loading ...
Jul 31, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 31, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 29, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Jul 29, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Jul 17, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 17, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 12, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 20, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 17, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 05, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 03, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
May 23, 2019

Major Issues Report

Current report, items 5.02, 5.07, and 9.01
Sep 07, 2017

Major Issues Report

神经内分泌的生物科学公司
Apr 29, 2016

[Rev.]Annual Report

Apr 29, 2016

[Rev.]Annual Report

FY 2015 ended 12/31/15 – amended
Jul 10, 2013

Correspondence

Jul 10, 2013

Correspondence

与美国证券交易委员会(SEC)的通信
Jun 26, 2013

Correspondence

Nov 22, 2010

Correspondence

Nov 15, 2010

Correspondence